News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
295,257 Results
Type
Article (21134)
Company Profile (21)
Press Release (274102)
Section
Business (73939)
Career Advice (435)
Deals (11724)
Drug Delivery (30)
Drug Development (74635)
Employer Resources (47)
FDA (8580)
Job Trends (6121)
News (164830)
Policy (14993)
Tag
Academia (1091)
Alliances (19751)
Alzheimer's disease (1154)
Antibody-drug conjugate (ADC) (89)
Approvals (8552)
Artificial intelligence (111)
Bankruptcy (107)
Best Places to Work (5451)
Breast cancer (195)
Cancer (1485)
Cardiovascular disease (106)
Career advice (389)
CAR-T (106)
Cell therapy (273)
Clinical research (62979)
Collaboration (364)
Compensation (119)
COVID-19 (1897)
C-suite (76)
Data (1433)
Diabetes (146)
Diagnostics (2054)
Earnings (31435)
Events (43386)
Executive appointments (280)
FDA (9259)
Funding (352)
Gene therapy (189)
GLP-1 (494)
Government (1894)
Healthcare (7446)
Infectious disease (1974)
Inflammatory bowel disease (90)
Interviews (76)
IPO (6606)
Job creations (987)
Job search strategy (340)
Layoffs (252)
Legal (2307)
Lung cancer (234)
Lymphoma (101)
Manufacturing (107)
Medical device (4134)
Medtech (4136)
Mergers & acquisitions (5321)
Metabolic disorders (430)
Neuroscience (1530)
NextGen: Class of 2025 (2007)
Non-profit (1355)
Northern California (1348)
Obesity (225)
Opinion (123)
Parkinson's disease (103)
Patents (100)
Patient recruitment (76)
People (19803)
Phase I (19673)
Phase II (28023)
Phase III (21143)
Pipeline (654)
Postmarket research (1902)
Preclinical (5468)
Radiopharmaceuticals (182)
Rare diseases (246)
Real estate (1506)
Regulatory (12109)
Research institute (1270)
Southern California (1135)
Startups (1372)
United States (10924)
Vaccines (466)
Weight loss (142)
Date
Today (123)
Last 7 days (513)
Last 30 days (1717)
Last 365 days (20881)
2025 (3292)
2024 (21050)
2023 (23353)
2022 (26763)
2021 (28227)
2020 (25244)
2019 (18497)
2018 (13950)
2017 (16178)
2016 (14224)
2015 (17060)
2014 (11401)
2013 (8504)
2012 (9025)
2011 (9372)
2010 (8873)
Location
Africa (298)
Asia (20454)
Australia (4383)
California (2957)
Canada (938)
China (290)
Colorado (122)
Connecticut (128)
Europe (43021)
Florida (419)
Georgia (104)
Illinois (153)
Indiana (163)
Japan (86)
Maryland (407)
Massachusetts (2170)
Michigan (91)
Minnesota (118)
New Jersey (883)
New York (943)
North Carolina (470)
Northern California (1348)
Ohio (99)
Pennsylvania (623)
South America (312)
Southern California (1135)
Texas (441)
Washington State (346)
295,257 Results for "transperfect trial interactive".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Gedeon Richter Selects Trial Interactive for Clinical Trial Management
TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, announced that Gedeon Richter selected Trial Interactive’s award-winning eTMF platform and TI Collaborate eClinical solution for its upcoming clinical trials.
March 25, 2024
·
3 min read
Pharm Country
TransPerfect Life Sciences and Innovaderm Research Expand Trial Interactive Partnership
TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced that Innovaderm will scale their implementation of Trial Interactive to further enable and optimize remote clinical operations.
February 15, 2022
·
4 min read
Depression
Neumora Shakes Up Phase III MDD Trials After January Miss
After failing to hit the primary endpoint in a Phase III trial, Neumora is remixing study parameters in two replicate trials, with data expected in the first half of 2026.
March 3, 2025
·
1 min read
·
Dan Samorodnitsky
Pain
Lexicon to Advance Non-Opioid Painkiller Despite Mid-Stage Trial Failure
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III trials before long.
March 3, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
Rare diseases
Novo’s Bispecific for Hemophilia Aces Phase III Pediatric Trial
Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III FRONTIER3 trial. The company plans to file for approval this year, hoping to compete in the hemophilia A space with Roche’s
blockbuster
Hemlibra.
February 7, 2025
·
2 min read
·
Dan Samorodnitsky
Psychedelics
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks after J&J secured FDA monotherapy approval for its esketamine nasal spray Spravato in the same indication.
February 3, 2025
·
2 min read
·
Dan Samorodnitsky
Drug Development
Akero Rebounds as Benefit Deepens in Key Mid-Stage MASH Trial
After missing the primary endpoint in the Phase IIb SYMMETRY trial, Akero Therapeutics’ lead molecule, efruxifermin, showed greater improvements after 96 weeks of treatment in an advanced disease population.
January 27, 2025
·
2 min read
·
Dan Samorodnitsky
FDA
When Are Confirmatory Trials ‘Underway’? FDA Releases New Accelerated Approval Guidance
Amid recent backlash stemming from market withdrawals and trial delays, the FDA seeks to further clarify its requirements for confirmatory trials for therapies seeking the shortened path to market.
January 7, 2025
·
3 min read
·
Heather McKenzie
Layoffs
Cargo Halts CAR T Trial, Lays Off 50% of Workforce in Pipeline Reset
CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a mid-stage trial of its lead program, firi-cel.
January 30, 2025
·
2 min read
·
Heather McKenzie
1 of 29,526
Next
